Methods of measuring the ability of a test compound to inactivate a biological target in cells of a subject

Details for Australian Patent Application No. 2004230596 (hide)

Owner Praecis Pharmaceuticals, Inc.

Inventors Gefter, Malcolm L.; Wang, Bryan; Thompson, Charles; Arico-Muendel, Christopher C.; Wakefield, James; Benjamin, Dennis

Agent Shelston IP

Pub. Number AU-A-2004230596

PCT Pub. Number WO2004/092728

Priority 60/460,920 07.04.03 US

Filing date 7 April 2004

Wipo publication date 28 October 2004

International Classifications

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/092728 Priority application(s): WO2004/092728

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230600-Fragments of fluorescent proteins for protein fragment complementation assays

2004230594-Plastic tube joint